Irbesartan Tablet
Product Images NDC 72162-2355

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 72162-2355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl721622355)

Label (Lbl721622355)
FDA Label Image

Structure (Spl Image1 Structure)

Structure (Spl Image1 Structure)
FDA Label Image

Figure 1 (Spl Image2 Figure1)

Figure 1 (Spl Image2 Figure1)
FDA Label Image

Figure 2 (Spl Image3 Figure2)

Figure 2 (Spl Image3 Figure2)
FDA Label Image

Figure 3 (Spl Image4 Figure3)

Figure 3 (Spl Image4 Figure3)
This text appears to list the results of a study or clinical trial comparing the effects of two medications, Losartan and Amlodipine, as well as a placebo, on some outcome measure. The data seems to show relative risk (RR) values for these comparisons at different follow-up time points. The study may have been monitoring certain health outcomes over time to evaluate the effectiveness of these medications.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.